Hyaluronic acid Recruiting Phase 4 Trials for Dry Eye Syndromes / Meibomian Gland Dysfunction (MGD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03318874Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction